Hybrid Conferencee

International Conference on Oncology, Molecular Biology and Cancer Therapeutics (ICOMBCT - 26)

19th - 20th December 2026 | St. George's, Bermuda

10% DISCOUNT

Maximum discount capped at $30. Activate your Scholarly Discount during the payment phase to lower your final checkout amount.

REVEAL OFFER
EARLY10
Sample Abstract
Download
Conference Brochure
Sample Full Paper
Download
Conference Notifications:

"Be sure to check this section regularly for all Research Plus International Conference updates. We’ll keep you informed about deadlines, event details, and more important notifications."

Call for Papers Extended:
"The deadline for full paper submissions has been extended for the Research Plus International Conference in St. George's. Submit your research by today to participate in one of the top conferences."
Certificate of Presentation:
"Present your research and receive a Certificate of Presentation to recognise your valuable contribution to the conference."
Abstract Submissions Open:
"Abstract submissions for the St. George's event are now open! Don’t miss the chance to present your research. Submit now."
Networking with Global Experts:
"Engage with researchers and professionals from around the world at the St. George's conference. Build collaborations and gain insights from leading experts."
Keynote Speaker Sessions:
"Don’t miss our Keynote Sessions in St. George's, featuring global leaders and innovators sharing their knowledge."
Best Paper & Best Paper Presentation Award:
"Submit your paper and stand a chance to win the Best Paper Presentation Award. The winner will be recognized at the conference in St. George's."
SDG-Inspired Conference Focus:
"Our conference will highlight research that addresses global sustainability, inclusive education, and solutions for environmental challenges."

Conference Session Tracks

SDG Wheel

Aligned with

UN Sustainable Development Goals

This conference contributes to global sustainability by aligning its research discussions and academic sessions with key United Nations Sustainable Development Goals. It fosters knowledge exchange, innovation, and collaborative engagement.

SDG 3
SDG 3 Good Health and Well-being
SDG 4
SDG 4 Quality Education
SDG 9
SDG 9 Industry, Innovation and Infrastructure
Track 01

Advancements in Precision Medicine

This track will explore the latest developments in precision medicine as it relates to oncology. Emphasis will be placed on personalized treatment strategies that enhance patient outcomes through tailored therapeutic approaches.

Track 02

Molecular Mechanisms in Cancer Biology

Focusing on the intricate molecular pathways involved in cancer biology, this track aims to elucidate the genetic and epigenetic factors that contribute to tumorigenesis. Presentations will highlight recent discoveries that inform our understanding of cancer progression.

Track 03

Innovations in Cancer Therapeutics

This session will showcase groundbreaking therapeutic strategies in the treatment of various cancers. Participants will discuss novel drug formulations, delivery systems, and combination therapies that are reshaping oncology.

Track 04

Tumor Microenvironment and Immune Response

This track will delve into the complex interactions between tumors and their microenvironment, particularly focusing on immune evasion mechanisms. Research presented will highlight how these interactions can be targeted for therapeutic benefit.

Track 05

Biomarkers in Cancer Diagnosis and Prognosis

The identification and validation of biomarkers are crucial for improving cancer diagnosis and prognosis. This session will cover the latest research on biomarkers that can predict treatment response and disease outcomes.

Track 06

Translational Oncology: Bridging Research and Practice

This track will emphasize the translation of laboratory findings into clinical applications in oncology. Discussions will center around successful case studies and the challenges faced in implementing research into practice.

Track 07

Immunotherapy: Current Trends and Future Directions

Focusing on the evolving field of immunotherapy, this session will address current trends, challenges, and future directions in harnessing the immune system to combat cancer. Presentations will include novel agents and combination strategies.

Track 08

Targeted Therapies in Oncology

This track will explore the development and application of targeted therapies in the treatment of cancer. Emphasis will be placed on the mechanisms of action, resistance, and clinical outcomes associated with these therapies.

Track 09

Cancer Epidemiology and Prevention

This session will focus on the epidemiological aspects of cancer, including risk factors, prevention strategies, and public health initiatives. Research presented will aim to inform policy and practice in cancer prevention.

Track 10

Emerging Technologies in Cancer Research

This track will highlight innovative technologies that are transforming cancer research, including genomics, proteomics, and bioinformatics. Participants will discuss how these technologies can enhance our understanding of cancer biology.

Track 11

Ethical Considerations in Cancer Research and Treatment

This session will address the ethical implications of cancer research and treatment, including patient consent, access to therapies, and the role of equity in healthcare. Discussions will aim to foster a responsible approach to oncology practices.